World Health Organization Raises Concern Over Acute Lack of Weight-Loss Jabs
Fewer than one in 10 patients who could benefit from weight-loss injections like Wegovy have access to them, warns the World Health Organization as it issues its first recommendations on the drugs.
With in excess of 1,000,000,000 individuals worldwide now classified as obese, it is urging increased and just availability to GLP-1 medication.
According to forecasts, over two billion will be living with obesity by 2030 if no action is taken.
"The latest guidelines acknowledges that obesity is a chronic disease that can be treated with comprehensive and ongoing treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and distribution challenges are significant barriers to widespread availability to the treatments that can aid individuals in losing significant weight, says the body.
Weight-Loss Drug Scarcity
Despite the present most favorable scenario, the manufacturing of GLP-1 therapies would only suffice for approximately 100 million people – under 10% of eligible patients, according to the WHO.
The advice encourages nations and manufacturers to expand availability, via approaches including licensing agreements.
A patent on the active ingredient – the primary ingredient of Novo Nordisk's Wegovy – is due to expire in multiple countries in 2026.
The Way Obesity Jabs Work
These medications imitate a natural hormone to delay gastric emptying, suppress the appetite and increase the sense of being full so individuals eat less.
Individuals commonly start to lose weight after several weeks of commencing the once-weekly jabs.
Evidence suggests patients may regain a significant portion a year later of discontinuing the medication, because their usual food cravings return.
Being above a healthy weight increases your risk for experiencing medical conditions, like type 2 diabetes, heart disease, stroke, and specific cancers.
Obesity impacts people in countries worldwide and was associated with 3.7 million fatalities worldwide in 2024, according to the WHO.
